microRNAs are differentially expressed in equine plasma of horses with osteoarthritis and osteochondritis dissecans versus control horses

• Published in: PloS one Vol. 19; no. 2; p. e0297303
• Main Authors: Antunes, Joshua, Salcedo-Jiménez, Ramés, Lively, Starlee, Potla, Pratibha, Coté, Nathalie, Dubois, Marie-Soleil, Koenig, Judith, Kapoor, Mohit, LaMarre, Jonathan, Koch, Thomas Gadegaard
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 23-02-2024; Public Library of Science (PLoS)
• Subjects: Analysis; Animals; Diagnosis; Genetic aspects; Health aspects; Horses; Horses - genetics; Joint Diseases; MicroRNA; MicroRNAs - genetics; MicroRNAs - metabolism; Osteoarthritis; Osteoarthritis - diagnosis; Osteoarthritis - genetics; Osteoarthritis - veterinary; Osteochondritis Dissecans - genetics; Osteochondritis Dissecans - veterinary; Synovial Membrane - metabolism; Canada
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0297303

Osteoarthritis (OA) is a leading cause of lameness in horses with no effective disease-modifying treatment and challenging early diagnosis. OA is considered a disease of the joint involving the articular cartilage, subchondral bone, synovial membrane, and ligaments. Osteochondritis dissecans (OCD) is a joint disease consisting of focal defects in the osteochondral unit which may progress to OA later in life. MicroRNAs (miRNAs) have been recognized as small non-coding RNAs that regulate a variety of biological processes and have been detected in biological fluids. MiRNAs are currently investigated for their utility as biomarkers and druggable targets for a variety of diseases. The current study hypothesizes that miRNA profiles can be used to actively monitor joint health and differences in miRNA profiles will be found in healthy vs diseased joints and that differences will be detectable in blood plasma of tested horses. Five horses with OA, OCD, and 4 controls (C) had blood plasma and synovial fluid collected. Total RNA, including miRNA was isolated before generating miRNA libraries from the plasma of the horses. Libraries were sequenced at the Schroeder Arthritis Institute (Toronto). Differential expression analysis was done using DESeq2 and validated using ddPCR. KEGG pathway analysis was done using mirPath v.3 (Diana Tools). 57 differentially expressed miRNAs were identified in OA vs C plasma, 45 differentially expressed miRNAs in OC vs C plasma, and 21 differentially expressed miRNAs in OA vs OCD plasma. Notably, miR-140-5p expression was observed to be elevated in OA synovial fluid suggesting that miR-140-5p may serve as a protective marker early on to attenuate OA progression. KEGG pathway analysis of differentially expressed plasma miRNAs showed relationships with glycan degradation, glycosaminoglycan degradation, and hippo signaling pathway. Interestingly, ddPCR was unable to validate the NGS data suggesting that isomiRs may play an integral role in miRNA expression when assessed using NGS technologies.